STAT News

STAT+: RevMed’s pancreatic cancer drug nears European approval

Following a green light from the FDA, European regulators have now recommended the approval of Revolution Medicines' Rasonque for pancreatic cancer.

By STAT News

1 min read
STAT+: RevMed’s pancreatic cancer drug nears European approval
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights